THERAVET news, videos and press releases
For more news please use our advanced search feature.
THERAVET - More news...
THERAVET - More news...
- EGEIRO's Board of Directors Acknowledges the Resignation of Enrico Bastianelli and Modifies Its Governance
- TheraVet provides an update on its 2023 half-year development and portfolio strategy
- TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago
- TheraVet Announces the Commercial Launch of a Local and Sustained Antibiotic Releasing Bone Substitute
- TheraVet Continues the Assessment of BIOCERA-VET in a New Clinical Program
- TheraVet reports Full-Year 2022 Financial Results and provides the preparatory documents for the General Assembly of June 1st, 2023
- TheraVet Launches its Osteosarcoma Reference Centers Program
- TheraVet Updates on Its Development and Portfolio Strategy
- TheraVet Signs an International Distribution Agreement for BIOCERA-VET® Covering 24 Countries
- TheraVet Announces the Start of the Assessment of BIOCERA-VET® in Horse Bone Cyst
- TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range
- TheraVet: BIOCERA-VET® Nominated for the Veterinary Innovation Award (AFVAC 2022)
- TheraVet Announces an Exclusive Distribution Agreement for BIOCERA-VET® in the USA
- TheraVet Announces Its Participation in the 2022 ESVOT Congress With 3 Scientific Communications
- TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities
- TheraVet Provides Its 2022 First Half-year Operational Update
- TheraVet Annonces the Commercial Launch of its BIOCERA-VET Product Line in the United States of America
- TheraVet Annonces the Commercial Launch of the Most Comprehensive Line of Bone Substitutes in the Veterinary Market
- TheraVet Signs a Distribution Agreement With Nuzoa, a Leading Spanish Company in the Distribution of Veterinary Products and Services
- TheraVet: General Meeting of June 2, 2022: Availability of Preparatory Documents
- TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation
- TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022
- TheraVet: Market-making Agreement with Banque Rothschild
- TheraVet: Commercial Launch of BIOCERA-VET® in United Kingdom and Ireland
- TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts
- TheraVet: Positive Results of BIOCERA-VET®-Bone Surgery Presented at the Annual Conference of the US Veterinary Orthopedic Society and Confirmed on a Larger Patients Cohort
- TheraVet Provides Its 2021 Second Half Operational Update
- TheraVet Strengthens Its Sales Organisation in France by Signing an Important Distribution Agreement for BIOCERA-VET®
- TheraVet Announces the Initiation of Coverage of Its Stock by Degroof Petercam
- TheraVet Is Strengthening Its Corporate Governance With the Appointment of Three New Independent Board Members
